Total Payments
$9,894
2023 Payments
$121.31
Companies
5
Transactions
89
Medicare Patients
4,993
Medicare Billing
$480,705
Payment Breakdown by Category
Other$5,650 (57.1%)
Research$2,500 (25.3%)
Food & Beverage$1,744 (17.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Entertainment | $5,650 | 3 | 57.1% |
| Unspecified | $2,500 | 1 | 25.3% |
| Food and Beverage | $1,744 | 85 | 17.6% |
Payments by Type
General
$7,394
88 transactions
Research
$2,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Resmed Corp | $8,150 | 4 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $1,536 | 81 | $0 (2020) |
| American Orthodontics Corporation | $121.31 | 1 | $0 (2023) |
| Beckman Coulter, Inc. | $64.59 | 1 | $0 (2018) |
| Harmony Biosciences LLC | $22.17 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $121.31 | 1 | American Orthodontics Corporation ($121.31) |
| 2020 | $96.71 | 6 | Jazz Pharmaceuticals Inc. ($74.54) |
| 2019 | $541.25 | 39 | JAZZ PHARMACEUTICALS INC. ($541.25) |
| 2018 | $562.57 | 19 | Jazz Pharmaceuticals Inc. ($497.98) |
| 2017 | $8,572 | 24 | Resmed Corp ($8,150) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2023 | American Orthodontics Corporation | EMPOWER-METAL (Device), EMPOWER-CERAMIC, RADIANCE | Food and Beverage | Cash or cash equivalent | $121.31 | General |
| Category: Orthodontic Prosthetics | ||||||
| 03/12/2020 | Jazz Pharmaceuticals Inc. | XYREM (Drug), SUNOSI | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROLOGY | ||||||
| 02/25/2020 | Jazz Pharmaceuticals Inc. | XYREM (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROLOGY | ||||||
| 02/21/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $11.09 | General |
| Category: Neurological Disorders | ||||||
| 02/20/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug), XYREM | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROLOGY | ||||||
| 02/10/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $11.08 | General |
| Category: Neurological Disorders | ||||||
| 01/24/2020 | Jazz Pharmaceuticals Inc. | XYREM (Drug), SUNOSI | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: PAIN | ||||||
| 12/05/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: PAIN | ||||||
| 11/12/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PAIN | ||||||
| 10/29/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: PAIN | ||||||
| 10/29/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: PAIN | ||||||
| 10/29/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: PAIN | ||||||
| 09/30/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: PAIN | ||||||
| 09/30/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: PAIN | ||||||
| 08/29/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: NEUROLOGY | ||||||
| 08/15/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $118.79 | General |
| Category: NEUROLOGY | ||||||
| 08/02/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PAIN | ||||||
| 08/02/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: PAIN | ||||||
| 07/12/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 07/12/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: PAIN | ||||||
| 06/18/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROLOGY | ||||||
| 06/18/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: NEUROLOGY | ||||||
| 06/18/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Monaco | Resmed Corp | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,236 | 1,418 | $716,462 | $100,357 |
| 2022 | 7 | 1,483 | 1,552 | $864,313 | $108,214 |
| 2021 | 5 | 1,122 | 1,252 | $616,630 | $136,326 |
| 2020 | 14 | 1,152 | 1,228 | $561,167 | $135,808 |
Total Patients
4,993
Total Services
5,450
Medicare Billing
$480,705
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 217 | 219 | $166,440 | $29,099 | 17.5% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 336 | 339 | $257,640 | $25,650 | 10.0% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2023 | 269 | 272 | $206,720 | $16,988 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 245 | 312 | $46,800 | $16,877 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $11,875 | $4,585 | 38.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 80 | $10,036 | $3,276 | 32.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 56 | $7,801 | $2,537 | 32.5% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 61 | 61 | $9,150 | $1,345 | 14.7% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2022 | 572 | 579 | $440,040 | $43,495 | 9.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 455 | 460 | $349,600 | $35,903 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 289 | 332 | $49,800 | $19,619 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 92 | 92 | $13,775 | $6,665 | 48.4% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 48 | 48 | $7,200 | $1,175 | 16.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 11 | 25 | $3,136 | $1,081 | 34.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 16 | 16 | $761.28 | $276.04 | 36.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 580 | 585 | $444,600 | $81,927 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 319 | 441 | $66,150 | $31,991 | 48.4% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2021 | 115 | 118 | $89,680 | $14,597 | 16.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 85 | 85 | $12,750 | $7,233 | 56.7% |
| 94762 | Overnight measurement of oxygen saturation in blood using ear or finger device | Office | 2021 | 23 | 23 | $3,450 | $578.68 | 16.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2020 | 368 | 370 | $281,200 | $66,357 | 23.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 327 | 387 | $73,948 | $20,445 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 121 | 125 | $31,250 | $9,379 | 30.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 92 | 98 | $18,000 | $8,935 | 49.6% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 12 | 12 | $36,000 | $7,134 | 19.8% |
About Dr. Wesley Fleming, MD
Dr. Wesley Fleming, MD is a Sleep Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205922945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wesley Fleming, MD has received a total of $9,894 in payments from pharmaceutical and medical device companies, with $121.31 received in 2023. These payments were reported across 89 transactions from 5 companies. The most common payment nature is "Entertainment" ($5,650).
As a Medicare-enrolled provider, Fleming has provided services to 4,993 Medicare beneficiaries, totaling 5,450 services with total Medicare billing of $480,705. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Location Irvine, CA
- Active Since 10/04/2006
- Last Updated 01/25/2008
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1205922945
Products in Payments
- Air Mini (Device) $4,075
- Xyrem (Drug) $919.78
- XYREM (Drug) $488.22
- SUNOSI (Drug) $127.57
- EMPOWER-METAL (Device) $121.31
- ACCESS 2 (Device) $64.59
- Wakix (Drug) $22.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.